title: Testosterone replacement alone for testosterone deficiency syndrome improves moderate lower urinary tract symptoms: one year follow-up.
abstract: OBJECTIVE
  To evaluate the actual impact of testosterone replacement therapy (TRT) on patients with lower urinary tract symptom (LUTS), without benign prostate hyperplasia (BPH) medication.
  
  
  METHODS
  Two hundreds forty-six patients underwent TRT using intramuscular injection of 3 months bases injection of testosterone 100 mg undecanoate over a year. Among them, 17 patients had moderate LUTS with a maximal flow rate of at least 10 ml/s but did not take any BPH-specific medication during TRT. The changes in prostate specific antigen (PSA), International Prostate Symptom Score (IPSS), and uroflowmetery were measured before and after TRT.
  
  
  RESULTS
  After TRT, PSA remained unchanged after a year of treatment (p=0.078). Compared with their counterparts (n=229), the patients without BPH medication had similar baseline prostate characteristics in all variables, including prostate volume, IPSS, maximal flow rate, voiding volume, and PSA, except the median amount of residual urine, which was higher in the patients without BPH medication (21 ml vs. 10 ml). In the no-BPH medication group, the total IPSS score was decreased significantly (p=0.028), both in storage symptoms (questionnaire 2, 4, 7) and voiding symptoms (questionnaire 1, 3, 5, 6), while the maximal flow rate and residual urine amount remained unchanged after a year of TRT. During the median follow up of 15.1 months, no patients experienced urinary retention, BPH-related surgery, or admission for urinary tract infection.
  
  
  CONCLUSIONS
  Over a year of TRT for the no-BPH medication patients with moderate LUTS and maintained a relatively high maximal flow rate and improved both storage and voiding symptoms, without the clinical progression of BPH or rising PSA.
authors: Department of Urology, Yeungnam University College of Medicine, Daegu, Korea.
authors: Young Hwii
authors: YH
authors: Ko
authors: Du Geon
authors: du G
authors: Moon
authors: Ki Hak
authors: KH
authors: Moon
keywords: Androgen analogues; Lower urinary tract symptoms; Prostatic hyperplasia
references: JAMA. 2006 Nov 15;296(19):2351-61
references: 17105798
references: J Clin Endocrinol Metab. 1992 Oct;75(4):1092-8
references: 1400877
references: Aging Male. 2011 Mar;14(1):53-8
references: 21171937
references: Horm Res. 2003;60(5):215-20
references: 14614225
references: Fertil Steril. 1995 May;63(5):1101-7
references: 7536692
references: Clin Exp Obstet Gynecol. 2002;29(2):117-20
references: 12171313
references: Urology. 2000 Mar;55(3):397-402
references: 10699620
references: Maturitas. 2008 Jul-Aug;60(3-4):248-52
references: 18774243
references: Eur Urol. 2010 Jan;57(1):123-31
references: 19825505
references: Aging Male. 2005 Jun;8(2):56-8
references: 16096159
references: BJU Int. 2006 Apr;97 Suppl 2:23-8; discussion 44-5
references: 16507050
references: Ther Clin Risk Manag. 2009 Jun;5(3):427-48
references: 19707253
references: Aging Male. 2008 Sep;11(3):146-9
references: 18821291
references: Aging Male. 2008 Jun;11(2):51-5
references: 18570055
references: J Urol. 2003 Dec;170(6 Pt 1):2517-22
references: 14634463
references: Prostate. 1993;23(2):99-106
references: 7690956
references: Urology. 2007 Apr;69(4):708-13
references: 17445656